Resuscitation Outcomes Consortium (ROC) Regional Clinical Centers-Milwaukee
Resuscitation Outcomes Consortium (ROC) Regional Clinical Centers-Milwaukee
批准号:
8599476
负责人:
TOM Paul AUFDERHEIDE
金额:
$13.65万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-01 至 2015-12-31
关键词:
Adolescent and Young AdultAgeBlood CirculationCanadaCardiacCardiopulmonary ArrestCardiovascular DiseasesCaringCause of DeathChildCitiesClinicalClinical ResearchClinical TrialsCommunitiesCoordination and CollaborationDataData Coordinating CenterDatabasesEmergency SituationEmergency medical serviceEnrollmentEstrogensFundingGenderGoalsHealthcareHeart ArrestHemorrhageHospitalsIV FluidInflammation MediatorsInformed ConsentInjuryInstitutesInterventionIntravenousLanguageLengthLifeMethodsMorbidity - disease rateNorth AmericaObservational StudyOutcomeOxidantsPatientsPentoxifyllinePerformancePhasePopulationProcessProviderPublished CommentQuality of lifeRaceRandomizedReperfusion InjuryReperfusion TherapyResearchResearch DesignResearch InfrastructureResearch PersonnelResourcesResuscitationSeriesSiteSpecific qualifier valueStructureTechniquesTelephoneTherapeuticTrainingTranslationsTraumaUnited Statesabstractingbaseclinical practicecollaborative trialdesignfollow-upimprovedmortalitynatural hypothermiaoutreachresearch and developmentrestorationrural areaskillstrauma care
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Description (provided by applicant): The Resuscitation Outcomes Consortium (ROC), consisting of 9 Regional Clinical Centers and a Data and Coordinating Center, is conducting multiple collaborative trials to achieve its long-term objective of rapid translation of promising scientific and clinical advances to improve resuscitation outcomes in the out-of hospital setting. Having established unprecedented infrastructure to successfully accomplish this goal (using exception from informed consent under emergency circumstances) in 245 EMS agencies and nearly 35,000 EMS providers covering a population of over 22 million people throughout North America, ROC has already demonstrated its ability to rapidly advance the fields of emergency cardiac and trauma care. This proposal presents the rationale for a 6-year renewal of funding for ROC to continue to improve outcomes for these important national healthcare issues. Three of the specific aims of the Consortium are to further advance these fields by: 1) continuing to expand and investigate the cardiac arrest and traumatic injury Epistry database (already the largest available resource of its kind in the world), 2) complete ongoing cardiac arrest and traumatic injury studies in the next 18 months, and 3) implement and complete multiple additional cardiac arrest and traumatic injury clinical trials. The scientifically most premising trauma interventions, targeted for completion during the renewal period include, 1) immediate versus delayed intravenous fluid to decrease hemorrhage and subsequent reperfusion injury, 2) intravenous estrogen to decrease the magnitude of reperfusion injury, and 3) intravenous pentoxifylline to reduce release of inflammatory mediators and reactive oxidants after reperfusion. The scientifically most premising cardiac arrest interventions include: 1) continuous compressions versus standard CPR to improve survival, and 2) implementing therapeutic hypothermia immediately following restoration of circulation to reduce reperfusion injury and improve survival and qualitative outcome. The research design, rationale and techniques for achieving these proposals are specified in the application. Through this 6-year renewal, ROC will leverage its unparalleled infra-structure to significantly reduce morbidity and mortality from cardiac arrest and traumatic injury. Finally, the Toronto site also plans to expand training opportunities by applying for the Clinical Research Development Skills Core. Cardiovascular disease is the leading cause of death in the United States. Trauma is the leading cause of death among children, adolescents and young adults (ages 1-44) in North America. Improvements in survival and quality of life from continuing the Resuscitation Outcomes Consortium initiative will significantly impact these major national healthcare issues. (End of Abstract)
Resume: In these excellent/very good applications the Resuscitation Outcomes Consortium (ROC) proposes to 1) continuing to expand and investigate the cardiac arrest and traumatic injury Epistry database, 2) complete ongoing cardiac arrest and traumatic injury studies, and 3) implement and complete multiple additional cardiac arrest and traumatic injury clinical trials. Strengths of the consortium are: the expertise of the principle investigators involved, the significance of ROC as a whole in improving out-of-hospital cardiopulmonary arrest (OOH-CA) and life-threatening traumatic injury (LTI), and the coordination / collaboration of the centers. There were several weaknesses that lowered enthusiasm. Some main ones that were discussed at length during review were: 1) Reviewers felt that trauma was underrepresented in the consortium and more outreach was needed to the trauma community; 2) There were concerns that when follow-up is done with patients on the phone and/or with materials that this needs to be done with languages other than English and Spanish since other languages are used in the US and Canada; 3) Concerns about the statement that in the prehospital setting providers call in to determine what study or study materials they are to administer to the patient- this was not considered effective or efficient; 4) There were significant concerns about the missing demographic data in the studies-especially those from Canada. Reviewers could not understand why in the very least a reasonable guess could not be made by the provider as to the race and gender of the patient and why a better method of tracking patients could not institute. In addition, there were comments about the focus of the Canadian centers only on city centers and not on rural areas and lack of outreach to the Canadian public. This consortium should significantly impact survival and quality of life in the US and Canada.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Renewal of The Mid-America CTSA Consortium (MACC) as a Regional Clinical Center for SIREN
-
批准号:10550446
-
项目类别:
-
资助金额:$47.36万
-
财政年份:2023
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Advanced REperfusion STrategies- The ARREST Trial
-
批准号:10022312
-
项目类别:
-
资助金额:$55.4万
-
财政年份:2018
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Advanced REperfusion STrategies- The ARREST Trial
-
批准号:9791473
-
项目类别:
-
资助金额:$73.62万
-
财政年份:2018
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Mid-America CTSA Consortium (MACC) as a Regional Clinical Center for the Strategies to Innovate EmeRgENcy Care Clinical Trials (SIREN) Network
-
批准号:10197231
-
项目类别:
-
资助金额:$14.17万
-
财政年份:2017
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Milwaukee Clinical Site Hub
-
批准号:7255011
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
The Milwaukee Clinical Site Hub
-
批准号:9068249
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Milwaukee Clinical Site Hub
-
批准号:7807900
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
The Milwaukee Clinical Site Hub
-
批准号:8706986
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
The Milwaukee Clinical Site Hub
-
批准号:8539080
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Milwaukee Clinical Site Hub
-
批准号:7417540
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Milwaukee Clinical Site Hub
-
批准号:8069144
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
The Milwaukee Clinical Site Hub
-
批准号:8396601
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Milwaukee Clinical Site Hub
-
批准号:7631247
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
The Milwaukee Clinical Site Hub
-
批准号:8857560
-
项目类别:
-
资助金额:$24.04万
-
财政年份:2007
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Resuscitation Outcomes Consortium (ROC) Regional Clinical Centers-Milwaukee
-
批准号:8210878
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2004
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Resuscitation Outcomes Consortium (ROC) Regional Clinical Centers-Milwaukee
-
批准号:7804283
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2004
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Milwaukee Regional Clinical Center
-
批准号:6941263
-
项目类别:
-
资助金额:$49.91万
-
财政年份:2004
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Resuscitation Outcomes Consortium (ROC) Regional Clinical Centers-Milwaukee
-
批准号:8780659
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2004
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Milwaukee Regional Clinical Center
-
批准号:7474541
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2004
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
Milwaukee Regional Clinical Center
-
批准号:6825121
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2004
-
负责人:TOM Paul AUFDERHEIDE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: